(Z)-3-(3-Hydroxy-4-methoxy-phenyl)-2-methoxy-1-(3,4,5-trimethoxy-phenyl)-propenone

ID: ALA364034

PubChem CID: 10215785

Max Phase: Preclinical

Molecular Formula: C20H22O7

Molecular Weight: 374.39

Molecule Type: Small molecule

Associated Items:

This compound is not in our inventory system

Names and Identifiers

Canonical SMILES:  CO/C(=C\c1ccc(OC)c(O)c1)C(=O)c1cc(OC)c(OC)c(OC)c1

Standard InChI:  InChI=1S/C20H22O7/c1-23-15-7-6-12(8-14(15)21)9-16(24-2)19(22)13-10-17(25-3)20(27-5)18(11-13)26-4/h6-11,21H,1-5H3/b16-9-

Standard InChI Key:  FNILUMSXQRNRNV-SXGWCWSVSA-N

Molfile:  

     RDKit          2D

 27 28  0  0  0  0  0  0  0  0999 V2000
   -2.9973    0.8792    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.9984    0.0518    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.2836   -0.3610    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.5672    0.0523    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.5700    0.8828    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.2854    1.2920    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.8571    1.2980    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.1411    0.8882    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.8602    2.1230    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -0.1380    0.0632    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.5780   -0.3466    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.5795   -1.1719    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.2947   -1.5816    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.0086   -1.1664    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.0028   -0.3371    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.2870    0.0689    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.7118    1.2915    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -3.7120    2.1165    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.7132   -0.3601    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -4.4274    0.0530    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.2838   -1.1860    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -2.9984   -1.5984    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.7142    0.0806    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    2.7251   -1.5752    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    2.7293   -2.4002    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.5718    1.3034    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.5687    2.1284    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0
 13 14  2  0
  5  7  1  0
 14 15  1  0
  3  4  2  0
 15 16  2  0
 16 11  1  0
  7  8  1  0
  1 17  1  0
 17 18  1  0
  7  9  2  0
  2 19  1  0
  4  5  1  0
 19 20  1  0
  8 10  2  0
  3 21  1  0
  2  3  1  0
 21 22  1  0
 10 11  1  0
 15 23  1  0
  5  6  2  0
 14 24  1  0
 11 12  2  0
 24 25  1  0
  6  1  1  0
  8 26  1  0
 12 13  1  0
 26 27  1  0
M  END

Associated Targets(Human)

TUBB1 Tclin Tubulin beta-1 chain (182 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
K562 (73714 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
HUVEC (11049 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 374.39Molecular Weight (Monoisotopic): 374.1366AlogP: 3.30#Rotatable Bonds: 8
Polar Surface Area: 83.45Molecular Species: NEUTRALHBA: 7HBD: 1
#RO5 Violations: HBA (Lipinski): 7HBD (Lipinski): 1#RO5 Violations (Lipinski):
CX Acidic pKa: 9.76CX Basic pKa: CX LogP: 2.55CX LogD: 2.55
Aromatic Rings: 2Heavy Atoms: 27QED Weighted: 0.43Np Likeness Score: 0.61

References

1. Ducki S, Mackenzie G, Lawrence NJ, Snyder JP..  (2005)  Quantitative structure-activity relationship (5D-QSAR) study of combretastatin-like analogues as inhibitors of tubulin assembly.,  48  (2): [PMID:15658859] [10.1021/jm049444m]
2. Ducki S, Rennison D, Woo M, Kendall A, Chabert JF, McGown AT, Lawrence NJ..  (2009)  Combretastatin-like chalcones as inhibitors of microtubule polymerization. Part 1: synthesis and biological evaluation of antivascular activity.,  17  (22): [PMID:19837593] [10.1016/j.bmc.2009.09.039]

Source